Using 20 thyroid cancer and 7 control cancer cell lines, we discovered that variants rs200077102 within FN1 and rs78588384 within CNTN5 displayed comparable low MAF in vitro as observed in the PTC blood and tumor samples. This evidence concerns the gene CNTN5 and neoplasm.